Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

NCT03830203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

621

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: BAT1806
DRUG: Actemra(EU-licensed)

Sponsor

Bio-Thera Solutions